Resistance in cancer: A target for drug discovery

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 4, Issue 5, 2004, Pages 457-460

  Searcey, Mark ^a   Patterson, Laurence H ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS[[2 (DIMETHYLAMINO N OXIDE)ETHYL]AMINO] 5,8 DIHYDROXYANTHRAQUINONE; ABELSON KINASE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CELL DNA; CYCLOPHOSPHAMIDE; CYTOCHROME P450; CYTOTOXIC AGENT; DACARBAZINE; DOXORUBICIN; DUOCARMYCIN A; DUOCARMYCIN B1; DUOCARMYCIN B2; DUOCARMYCIN SA; GYRASE INHIBITOR; IMATINIB; IRINOTECAN; MITOXANTRONE; OXAZAPHOSPHORINE DERIVATIVE; PACLITAXEL; PRODRUG; PROTEIN TYROSINE KINASE INHIBITOR; PYRINDAMYCIN A; PYRINDAMYCIN B; RACHELMYCIN; RADIOSENSITIZING AGENT; THIOTEPA; TRABECTEDIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; YATAKEMYCIN;

CANCER CHEMOTHERAPY; CANCER RESISTANCE; CLINICAL TRIAL; DNA REPAIR; DRUG DESIGN; DRUG MECHANISM; DRUG METABOLISM; DRUG RESEARCH; DRUG TARGETING; DRUG TISSUE LEVEL; DRUG TRANSPORT; HUMAN; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SOLID TUMOR; STRUCTURE ACTIVITY RELATION; TARGET CELL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DNA; DNA REPAIR; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; MODELS, CHEMICAL; NEOPLASMS; OXYGEN; TIME FACTORS;

EID: 4444339613     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011043352722     Document Type: Review

References (14)

1. Strausberg, R. L.; Simpson, A. J. G.; Old, L. J.; Riggins, G. J. Nature, 2004, 429, 469.
2. Schrieber, S. L. Science, 2000, 287, 1964.
3. Aune, G. J.; Furuta, T.; Pommier, Y. Anticancer Drugs, 2002, 13, 545.
4. Igarishi, Y.; Futamata, K.; Fujita, T.; Sekine, A.; Senda, H.; Naoki, H.; Furami, T. J. Antibiotics, (Tokyo) 2003, 56, 107.
5. Ingelman-Sundberg M. Toxicology, 2002, 181-182, 447.
6. Patterson, L. H.; Murray, G. I. Curr. Pharm. Des., 2002, 8, 1335.
7. Erion, M. D.; Reddy, K. R.; Boyer, S. H.; Matelich, M. C.; Gomez-Galeno, J.; Lemus, R. H.; Ugarkar, B. G.; Colby, T. J.; Schanzer, J.; Van Poelje, P. D. J. Am. Chem. Soc., 2004, 126, 5154.
8. Patterson, L. H.; McKeown, S. R. Br. J. Cancer, 2000, 83, 1589.
9. Lane, C. S.; Griffiths, W. J.; Fuller, B. J.; Davidson, B. R.; Hewes, J.; Nisar, S.; Welham, K. J.; Patterson, L. H. Eur. J. Cancer, in press.
10. Raleigh, S. M.; Wanogho, E.; Burke, M. D.; McKeown, S. R.; Patterson, L. H. Int. J. Radiat. Oncol. Biol. Phys., 1998, 42, 763.
11. Chen, L.; Waxman, D.J. Cancer Res., 1995, 55, 581.
12. Searcey, M. Curr. Pharm. Des., 2002, 8, 1375.
13. Boger, D. L.; Munk, S. A.; Zarrinmayeh, H. J. Am. Chem. Soc., 1991, 113, 3980.
14. Pors, K.; Paniwnyk, Z.; Teesdale-Spittle, P.; Plumb, J. A.; Willmore, E.; Austin, C. A.; Patterson, L. H. Mol. Cancer Ther., 2003, 2, 607.